Combined hepatitis C virus (HCV) antigen-antibody detection assay does not improve diagnosis for seronegative individuals with occult HCV infection

Journal of Clinical Microbiology

Volumn 44, Issue 12, 2006, Pages 4559-4560

  Quiroga, Juan A ^a   Castillo, Inmaculada ^a   Pardo, Margarita ^a   Rodríguez Iñigo, Elena ^a   Carreño, Vicente ^a  

^a Fundacion para el Estudio de Las Hepatitis Virales   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; MALE; NONHUMAN; PRIORITY JOURNAL; SERODIAGNOSIS; SEROLOGY; VIRUS DETECTION;

HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; SENSITIVITY AND SPECIFICITY;

HEPATITIS C VIRUS;

EID: 33845565035     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01440-06     Document Type: Article

References (11)

1. Ansaldi, F., B. Bruzzone, G. Testino, M. Bassetti, R. Gasparini, P. Crovari, and G. Icardi. 2006. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection. J. Viral Hepat. 13:5-10.
2. Castillo, I., M. Pardo, J. Bartolomé, N. Ortiz-Movilla, E. Rodríguez-Iñigo, S. de Lucas, C. Salas, J. A. Jiménez- Hefferman, A. Pérez-Mota, J. Graus, J. M. López-Alcorocho, and V. Carreño. 2004. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J. Infect. Dis. 189:7-14.
3. Castillo, I., E. Rodríguez-Iñigo, J. Bartolomé, S. de Lucas, N. Ortíz-Movilla, J. M. López-Alcorocho, M. Pardo, and V. Carreño. 2005. Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection. Gut 54:682-685.
4. Laperche, S., N. Le Marrec, A. Girault, F. Bouchardeau, A. Servant-Delmas, M. Maniez-Montreuil, P. Gallian, T. Levayer, P. Morel, and N. Simon. 2005. Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection. J. Clin. Microbiol. 43:3877-3883.
5. Laperche, S., M. H. Elghouzzi, P. Morel, M. Asso-Bonnet, N. Le Marrec, A. Girault, A. Servant-Delmas, F. Bouchardeau, M. Deschaseaux, and Y. Piquet. 2005. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing? Transfusion 45:1965-1972.
6. Post, J. J., Y. Pan, A. J. Freeman, C. E. Harvey, P. A. White, P. Palladinetti, P. S. Haber, G. Marinos, M. H. Levy, J. M. Kaldor, K. A. Dolan, R. A. French, A. R. Lloyd, W. D. Rawlinson, and Hepatitis C Incidence and Transmission in Prisons Study (HITS) Group. 2004. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort. J. Infect. Dis. 189:1846-1855.
7. Quiroga, J. A., and V. Carreño. 2005. HCV-indeterminate blood donors or occult HCV infection? Lancet 365:1540-1541.
8. Schnuriger, A., S. Dominguez, M. A. Valantin, R. Tubiana, C. Duvivier, J. Ghosn, A. Simon, C. Katlama, and V. Thibault. 2006. Early detection of hepatitis C virus infection by use of a new combined antigen-antibody detection assay: potential use for high-risk individuals. J. Clin. Microbiol. 44:1561-1563.
9. Semmo, N., E. Barnes, C. Taylor, J. Kurtz, G. Harcourt, N. Smith, and P. Klenerman. 2005. T-cell responses and previous exposure to hepatitis virus in indeterminate blood donors. Lancet 365:327-329.
10. Takaki, A., M. Wiese, G. Maertens, E. Depla, U. Seifert, A. Liebetrau, J. L. Miller, J. L., M. P. Manns, and B. Rehermann. 2000. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat. Med. 6:578-582.
11. Toyoda, H., T. Kumada, S. Kiriyama, Y. Sone, M. Tanikawa, Y. Hisanaga, T. Kuzuya, T. Honda, K. Hayashi, I. Nakano, Y. Katano, and H. Goto. 2005. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy. Clin. Infect. Dis. 15:49-54.